TiGenix Achieves First Ever Success In Allogeneic Stem Cell Phase 3 Trial – Seeking Alpha
|
TiGenix Achieves First Ever Success In Allogeneic Stem Cell Phase 3 Trial
Seeking Alpha Not only does Cx601 become the first ever recorded successful allogeneic "off-the-shelf" stem cell therapy to go through a large, randomized controlled trial, but also it is first and foremost a solid product which answers an unmet therapeutic need in … |
